ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

TG THERAPEUTICS, INC.

TGTX

$55.11

+$2.03 (+3.81%)

Price as of Oct 9, 2026 21:32 UTC

8.6 B

Market Cap (Mid Cap)

37%

IV Rank

56.3%

Implied Volatility

Nov 02

Next Earnings

Technical Signals as of Oct 7
Mixed
4 of 7

Trend

  • Above 20-day average $54.83
  • Above 50-day average $53.80
  • Above 200-day average $43.70 · +21.2%
  • Moving averages stacked 20 > 50 > 200

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) 132d ago

Volume

  • Below-average volume 0.8x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

0.07

Bullish skew

Implied Volatility

56.3%

0% percentile

IV vs Realized

Options rich

30d HV 37.0%

Options Heat Map

Delta-risk grid for TGTX options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

0 buys 4 sells
Date Insider Title Type Shares Value Since Trade
Sep 10, 2026 Charney Laurence N Sell 5,000 $274,800 -2.9%
Aug 07, 2026 Charney Laurence N Gift 500 $0 +7.2%
Aug 07, 2026 Charney Laurence N Gift 450 $0 +7.2%
Aug 06, 2026 Charney Laurence N Gift 5,100 $0 +7.6%
Jun 11, 2026 Lonial Sagar Other 8,325 $0 +11.0%
Jun 11, 2026 HUME DANIEL Other 8,325 $0 +11.0%
Jun 11, 2026 Echelard Yann Other 8,325 $0 +11.0%
Jun 11, 2026 Charney Laurence N Other 8,325 $0 +11.0%
Jun 11, 2026 Lonial Sagar Grant 8,325 $0 +11.0%
Jun 11, 2026 Hoberman Kenneth Grant 8,325 $0 +11.0%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 10, 2026 Q2 2026 $0.34
Aug 03, 2026 Q2 2026 $0.33
Jun 30, 2026 Q2 2026 $0.33 $0.05 -85.0% Miss
Mar 31, 2026 Q1 2026 $0.30 $0.18 -40.1% Miss
Dec 31, 2025 Q4 2025 $0.36 $0.14 -60.9% Miss
Sep 30, 2025 Q3 2025 $0.22 $0.16 -28.7% Miss
Jun 30, 2025 Q2 2025 $0.22 $0.17 -23.3% Miss
Mar 31, 2025 Q1 2025 $0.19 $0.03 -83.8% Miss

Track TGTX with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for TGTX and your entire portfolio.